Investors Alert: Deadline Approaches in Assertio Holdings Class Action Lawsuit

LOS ANGELES, March 1, 2024 – Glancy Prongay & Murray LLP ("GPM"), a prominent law firm representing investors nationwide, is issuing a final call to investors regarding the approaching deadline to become a lead plaintiff in the class action lawsuit against Assertio Holdings, Inc. ASRT. The deadline for submitting a lead plaintiff motion is March 5, 2024. This lawsuit pertains to individuals who acquired shares of ASRT, a commercial pharmaceutical company based in Lake Forest, Illinois, known for providing medications in neurology, hospital care, and pain and inflammation management.

Understanding the Class Action

This legal recourse is in response to allegations that Assertio Holdings may have issued materially misleading business information to the investing public. Investors who purchased shares of ASRT during the class period and incurred losses are urged to contact GPM to discuss their legal rights in this matter.

Key Dates and Participation

Investors should be aware that the March 5, 2024 deadline is critical, as it is the last day to file a lead plaintiff motion. Those who are affected by the alleged misconduct and wish to take an active role in the litigation have the opportunity to apply for the position of lead plaintiff through legal counsel. However, it is not mandatory for shareholders to assume this role in order to share in any potential class recovery. GPM advises investors to consult with legal experts to understand the process and implications of the lawsuit.

The outcome of this legal battle might significantly affect Assertio Holdings' business profile and stock performance. As the case unfolds, shareholders and the broader market alike are closely observing the developments surrounding Assertio Holdings and the legal proceedings.

investor, deadline, lawsuit